Latest papers

[Other therapeutic alternatives: radiotherapy and chemotherapy]

[Surgical treatment of vagal paragangliomas]

[History and epidemiology]

[Anesthesia in head and neck paragangliomas]

[Diagnosis and follow-up of head and neck paragangliomas. Contributions of nuclear medicine]

[Intraoperative use of activated recombinant factor VII in a patient with brain cancer]

[Relevance of nuclear medicine in the diagnosis and treatment of malignant paraganglioma]

Primary pulmonary paraganglioma.

Rare presentation of familial paraganglioma without evidence of mutation in the SDH, RET and VHL genes: towards further genetic heterogeneity.

Pharmacological treatment of a patient with first-bite syndrome.

PHD2 mutation and congenital erythrocytosis with paraganglioma.

Impact of screening kindreds for SDHD p.Cys11X as a common mutation associated with paraganglioma syndrome type 1.

Octreo-SPECT/CT imaging for accurate detection and localization of suspected neuroendocrine tumors.

Radiolabeled DOTATOC in patients with advanced paraganglioma and pheochromocytoma.

Detection and treatment of pheochromocytomas and paragangliomas: current standing of MIBG scintigraphy and future role of PET imaging.

Unusual location of a cervical paraganglioma between the thyroid gland and the common carotid artery: case report.

Biochemically silent abdominal paragangliomas in patients with mutations in the succinate dehydrogenase subunit B gene.

Current assessment and management of glomus tumors.

Clinical manifestations of familial paraganglioma and phaeochromocytomas in succinate dehydrogenase B (SDH-B) gene mutation carriers.

[Cystoscopy-assisted partial cystectomy for paraganglioma of the urinary bladder]